1. HOME
2. Research Insight
3. Smith+Nephew (UK) and MEDIPOST Co., Ltd. (South Korea) are Leading Players in the Stem Cell Therapy Market

The global stem cell therapy market is projected to reach USD 558 million by 2027 from USD 257 million in 2022, at a CAGR of 16.8% during the forecast period. One of the key driving factors of the stem cell therapy market is the increase in GMP certification approvals for cell therapy production facilities. Companies are increasingly focus on gaining GMP approvals for stem cell therapy production facilities. These approvals are likely to enhance the quality and efficiency of production facilities and increase overall market growth for stem cell therapy products.

The market for stem cell therapy is competitive and highly consolidated, with key players strategizing to capture the market. Prominent players in the stem cell therapy market include Smith+Nephew (UK), MEDIPOST Co., Ltd. (South Korea), Anterogen Co., Ltd. (South Korea), CORESTEM (South Korea), Pharmicell Co., Ltd. (South Korea), NuVasive, Inc. (US), RTI Surgical (US), AlloSource (US), JCR Pharmaceuticals Co., Ltd. (Japan), Takeda Pharmaceutical Company Limited (Japan), Holostem Terapie Avanzate Srl (Italy), Orthofix (US), Regrow Biosciences Pvt Ltd. (India), and STEMPEUTICS RESEARCH PVT LTD. (India).

To know about the assumptions considered for the study download the pdf brochure

Smith+Nephew (UK)

Smith+Nephew (UK) caters to the stem cell therapy market via its advanced wound management business segment. Allogeneic stem cell therapies such as Bio4 (musculoskeletal disorders), Grafix, and Stravix (treatment of wounds & injuries) are a part of the company’s product portfolio. Smith+Nephew is recognized by its robust presence across different geographies including, China, UK, and North America. The company’s key focus lies in product development and commercialization of stem cell therapies to sustain market competition.

MEDIPOST Co., Ltd. (South Korea)

MEDIPOST Co., Ltd. (South Korea) has a strong market presence in the Asia Pacific region. The company offers stem cell therapy products that cater to patients suffering from musculoskeletal disorders. MEDIPOST Co., Ltd. Has adopted organic growth strategies and has a prime focus on development and commercialization of stem cell therapy candidates in pipeline. Therapeutic applications such as neurological disorders and pulmonary ailments are two of the key areas of investments for the company through which it is expected to broaden its hold on the stem cell therapy market.

Related Reports:

Stem Cell Therapy Market by Type (Allogeneic, Autologous), Cell Source (Adipose Tissue-derived MSC, Bone Marrow, Placenta/Umbilical Cord), Therapeutic Application (Musculoskeletal, Wounds, Surgeries, Cardiovascular, Neurological) - Global Forecast to 2027

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]